Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

NAVB
Navidea Biopharmaceuticals Inc
stock NYSEAMERICAN

Market Open
9/21/2023 2:40:30 PM EDT
0.0929USD-6.351%(-0.0063)4,150,240
0.0862Bid   0.1015Ask   0.0153Spread IEX
Pre-market
9/21/2023 9:28:57 AM EDT
0.0994USD+0.202%(+0.0002)1,300
After-hours
9/20/2023 4:01:30 PM EDT
0.1000USD+0.806%(+0.0008)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
9.298M
CEO
Jed Latkin
Headquarters
Dublin, Ohio, USA
Industry
Biotechnology
Next Earnings
2023-11-14 (54d)
Last Split
2019-04-261for20reverse
Related
IMMUFONRAMAGCAHGELLYICADXLV
NAVB Stats
Avg. Vol. 10 Day
8,889,985
Avg. Vol. 30 Day
4,699,577
Employees
11
Market Cap
9,297,839
Shares Out.
100,084,385
P/E Ratio
-1.64
EPS (ttm)
-0.191
On/Off Exchange
40%/60%
6 Month Beta
-0.44
1 Year Beta
0.08
2 Year Beta
0.12
3 Year Beta
0.28
52 Week Low
0.06
52 Week High
0.35
SMA50
0.09
SMA200
0.16
1 Week
-22.58%
1 Month
+10.60%
3 Month
+0.11%
6 Month
-72.67%
1 Year
-62.86%
2 Year
-94.05%
5 Year
-98.23%
Profile
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

NAVB Stock Summary

Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) stock price today is $0.0929, and today's volume is 4,150,240. NAVB is down -6.351% today. The 30 day average volume is 4,699,577. NAVB market cap is 9.298M with 100,084,385 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC